PO.IM01.01 · 免疫学

一种产生TNF的中性粒细胞亚群驱动年龄依赖性肝毒性

A TNF-producing neutrophil subset drives age-dependent hepatotoxicity

海报缩略图:一种产生TNF的中性粒细胞亚群驱动年龄依赖性肝毒性
编号 169 展板 12 时间 4/19 02:00–05:00 区域 Section 8 主讲 Jin Lee, PhD
分会场 Immune Cell Biology and Tumor-Immune Crosstalk
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Jin Lee1, Yiming Gao1, Yufei Zhang1, Aaron Havas2, Peter Adams2, Gerald S. Shadel3, Susan M. Kaech3, Gen-Sheng Feng1

1University of California San Diego - UCSD, La Jolla, CA,2Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA,3Salk Institute for Biological Studies, La Jolla, CA

摘要 Abstract

中文摘要
衰老加剧癌症治疗有害效应的机制仍知之甚少。本研究中我们发现,合成dsRNA(polyIC)能有效抑制年轻小鼠的肝脏肿瘤,却在老年小鼠中诱发致死性肝坏死。单细胞及功能分析揭示了一个CD14⁺中性粒细胞亚群,其特征为仅在老年肝脏中由polyIC强烈诱导TNFalpha。NR3C1表达受损以及NF-κB和AP-1信号升高,驱动老年肝脏中细胞偏向Tnf⁺而非Saa1⁺中性粒细胞。中和TNF可挽救polyIC诱导的死亡,同时增强其在老年小鼠中的抗肿瘤效应。生物信息学分析显示,Tnf⁺Saa1⁻中性粒细胞基因特征与60岁以上肝癌患者生存率下降显著相关。本研究揭示了老年肝脏中一种此前未知的有害机制,该机制在基础条件下无法检测。我们提供了一种新策略,通过减轻治疗相关毒性来改善老年患者的治疗结局。
查看英文原文 English abstract
The mechanisms by which aging contributes to the detrimental effect of cancer therapy remain poorly understood. Herein we show that while a synthetic dsRNA (polyIC) effectively suppresses liver tumors in young mice, it induces lethal liver necrosis in aged mice. Single-cell and functional analyses unearthed a CD14⁺ neutrophil subset featured by robust TNFalpha induction by polyIC exclusively in the aged liver. Impaired NR3C1 expression and elevated NF-κB and AP-1 signaling drive a skewing toward Tnf⁺ over Saa1⁺ neutrophils in the aged liver. TNF neutralization rescued polyIC-induced mortality, while also enhancing its antitumor effect in aged mice. Bioinformatic analysis revealed significant association of a Tnf⁺Saa1⁻ neutrophil gene signature with reduced survival in liver cancer patients over 60. This study uncovers a previously unknown detrimental mechanism in the aged liver, which is undetectable under basal conditions. We provide a new strategy to improve therapeutic outcomes in elderly patients by mitigating treatment-associated toxicity.
利益披露 Disclosure
J. Lee, None.. Y. Gao, None.. Y. Zhang, None.. A. Havas, None.. P. Adams, None.. G. S. Shadel, None.. S. M. Kaech, None.. G. Feng, None.

← 返回 AACR 2026 检索